Cargando…

Terlipressin versus Norepinephrine in the Treatment of Hepatorenal Syndrome: A Systematic Review and Meta-Analysis

BACKGROUND: Hepatorenal syndrome (HRS) is a severe and progressive functional renal failure occurring in patients with cirrhosis and ascites. Terlipressin is recognized as an effective treatment of HRS, but it is expensive and not widely available. Norepinephrine could be an effective alternative. T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nassar Junior, Antonio Paulo, Farias, Alberto Queiroz, d’ Albuquerque, Luiz Augusto Carneiro, Carrilho, Flair José, Malbouisson, Luiz Marcelo Sá
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159336/ https://www.ncbi.nlm.nih.gov/pubmed/25203311 http://dx.doi.org/10.1371/journal.pone.0107466

Ejemplares similares

Terlipressin in the treatment of hepatorenal syndrome: A systematic review and meta-analysis
por: Wang, Haiqing, et al.
Publicado: (2018)

Terlipressin Versus Norepinephrine for Septic Shock: A Systematic Review and Meta-Analysis
por: Huang, Po, et al.
Publicado: (2019)

Hepatorenal syndrome:Response to terlipressin and albumin and its determinants
por: Sarwar, Shahid, et al.
Publicado: (2016)

Good Enough? Terlipressin, Hepatorenal Syndrome, and the Usage of RRT
por: Belcher, Justin M.
Publicado: (2023)

Terlipressin effect on hepatorenal syndrome: Updated meta‐analysis of randomized controlled trials
por: Mohamed, Mohamed M G, et al.
Publicado: (2021)

An investigation of reconstituted terlipressin infusion stability for use in hepatorenal syndrome
por: Bui, Thi Ngoc Nhieu, et al.
Publicado: (2020)

The Effect of Terlipressin on Renal Replacement Therapy in Patients with Hepatorenal Syndrome
por: Velez, Juan Carlos Q., et al.
Publicado: (2023)

Cardiohepatic Interactions - from Humoral Theory to Organ Transplantation
por: Silvestre, Odilson Marcos, et al.
Publicado: (2014)

Survival benefits of terlipressin and non-responder state in hepatorenal syndrome: A meta-analysis
por: Hiremath, Sharanabasayyaswamy B., et al.
Publicado: (2013)

The Current Management of Hepatorenal Syndrome–Acute Kidney Injury in the United States and the Potential of Terlipressin
por: Flamm, Steven L., et al.
Publicado: (2021)

Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: Few Concerns
por: Khera, Daisy, et al.
Publicado: (2023)

Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome
por: Kim, Hae Rim, et al.
Publicado: (2013)

Terlipressin-Induced Peripheral Cyanosis in a Patient with Liver Cirrhosis and Hepatorenal Syndrome
por: Chiang, Chi-Wen, et al.
Publicado: (2019)

Terlipressin for the Prevention and Treatment of Renal Decline in Hepatorenal Syndrome: A Drug Profile
por: Ayyad, Ahlam, et al.
Publicado: (2023)

Abstract No.: ABS0369: Comparison of norepinephrine and terlipressin versus norepinephrine alone for management of septic shock: A randomised control study.
por: Sahoo, Pallavi
Publicado: (2022)

Terlipressin and albumin for type 1 hepatorenal syndrome: does bacterial infection affect the response?
por: Altun, Reskan, et al.
Publicado: (2015)

Real‐world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome
por: Moore, Kevin, et al.
Publicado: (2020)

Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: A Randomized Control Study
por: Sahoo, Pallavi, et al.
Publicado: (2022)

Vasopressin analog terlipressin attenuates kidney injury in hemorrhagic shock
por: Cardoso de Castro, Letícia Urbano, et al.
Publicado: (2016)

Comparison of first-line and second-line terlipressin versus sole norepinephrine in fulminant ovine septic shock
por: Kampmeier, Tim G., et al.
Publicado: (2018)

Treatment-Related Cost Analysis of Terlipressin for Adults with Hepatorenal Syndrome with Rapid Reduction in Kidney Function
por: Huang, Xingyue, et al.
Publicado: (2023)

Author Reply: Comparison of Norepinephrine and Terlipressin vs Norepinephrine Alone for Management of Septic Shock: A Randomized Control Study
por: Sahoo, Pallavi, et al.
Publicado: (2023)

Terlipressin versus Norepinephrine to Prevent Milrinone-Induced Systemic Vascular Hypotension in Cardiac Surgery Patient with Pulmonary Hypertension
por: Abdelazziz, Mai Mohsen, et al.
Publicado: (2019)

Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence
por: Bai, Zhaohui, et al.
Publicado: (2020)

Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studies
por: Curry, Michael P., et al.
Publicado: (2023)

Addition of terlipressin to norepinephrine in septic shock and effect of renal perfusion: a pilot study
por: Wang, Jinlong, et al.
Publicado: (2022)

HIGHER VALUES IN LIVER ELASTOGRAPHY AND MELD SCORE ARE MORTALITY PREDICTORS ON LIVER TRANSPLANT WAITING LIST
por: NACIF, Lucas Souto, et al.
Publicado: (2018)

Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute‐on‐chronic liver failure
por: Wong, Florence, et al.
Publicado: (2022)

Role of Terlipressin in Patients With Hepatorenal Syndrome-Acute Kidney Injury Admitted to the ICU: A Substudy of the CONFIRM Trial
por: Karvellas, Constantine J., et al.
Publicado: (2023)

Terlipressin-Induced Skin Necrosis While Managing Hepatorenal Syndrome: A Rare Case Report From North India
por: Sudan, Sourav, et al.
Publicado: (2023)

A Systematic Review of the Emerging Treatment for Hepatorenal Syndrome With a Principal Focus on Terlipressin: A Recent FDA-Approved Drug
por: Thangaraj, Santhosh Raja, et al.
Publicado: (2023)

Effects of terlipressin as early treatment for protection of brain in a model of haemorrhagic shock
por: Ida, Keila Kazue, et al.
Publicado: (2015)

Endothelin-1/Nitric Oxide Ratio as a Predictive Factor of Response to Therapy With Terlipressin and Albumin in Patients With Type-1 Hepatorenal Syndrome
por: Abdel-Razik, Ahmed, et al.
Publicado: (2020)

Evaluation of simplified acute physiology score 3 performance: a systematic review of external validation studies
por: Nassar, Antonio Paulo, et al.
Publicado: (2014)

Terlipressin combined with conservative fluid management attenuates hemorrhagic shock-induced acute kidney injury in rats
por: Castro, Leticia Urbano Cardoso, et al.
Publicado: (2022)

Terlipressin or Europressin?
por: Leone, Marc
Publicado: (2009)

Safety and efficacy of terlipressin in acute-on-chronic liver failure with hepatorenal syndrome-acute kidney injury (HRS-AKI): a prospective cohort study
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Portal vein surgical treatment on non-tumoral portal vein thrombosis in liver transplantation: Systematic Review and Meta-Analysis
por: Nacif, Lucas S., et al.
Publicado: (2021)

Terlipressin-induced hyponatraemia
por: Gray, R, et al.
Publicado: (2014)

Technological Innovation in Outpatient Assistance for Chronic Liver Disease and Liver Transplant Patients During the Coronavirus Disease Outbreak: A Method to Minimize Transmission
por: Ono, Suzane Kioko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ohm74dclvlfjm1mf8fjhce4238